Denator

About:

Denator develops and markets products that stabilize biological tissues and fluids from the moment of sampling.

Website: http://www.denator.com

Twitter/X: denatorab

Top Investors: Almi Invest, EASME - EU Executive Agency for SMEs, SGP Group, Servisen Investment Management, T-bolaget

Description:

Denator develops and markets products that stabilize biological tissues and fluids from the moment of sampling. Utilizing a patent-pending technology to instantly and completely stop the degradation process and maintain sample stability thereafter, Denator aims to become the leading supplier of instruments and consumables that enable scientists to stabilize biological tissues and fluids at the moment of sampling thereby enhancing the quality and value of subsequent analytical results.

Total Funding Amount:

$8.38M

Estimated Revenue Range:

$1M to $10M

Headquarters Location:

Gothenburg, Vastra Gotaland, Sweden

Founded Date:

2004-01-01

Contact Email:

info(AT)aspectechnologies.com

Founders:

Karl Skold, Marcus Soderquist

Number of Employees:

11-50

Last Funding Date:

2015-07-01

IPO Status:

Private

Industries:

© 2025 bioDAO.ai